Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 46.82
+0.63 (1.36%)
Aug 4, 2026, 3:04 PM CST
SHE:300841 Market Cap
SHE:300841 has a market cap or net worth of 6.08 billion as of August 4, 2026. Its market cap has decreased by -41.05% in one year.
Market Cap
6.08B
Enterprise Value
5.06B
Revenue
1.20B
Ranking
n/a
PE Ratio
26.86
Stock Price
46.82
ChartMarket Cap Chart
Since June 16, 2020, SHE:300841's market cap has increased from 6.08B to 6.08B, an increase of 0.07%. That is a compound annual growth rate of 0.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 6.08B | -35.21% |
| Dec 31, 2025 | 9.39B | 34.30% |
| Dec 31, 2024 | 6.99B | -32.58% |
| Dec 29, 2023 | 10.37B | -8.37% |
| Dec 30, 2022 | 11.32B | -40.88% |
| Dec 31, 2021 | 19.14B | -31.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 7.65B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 7.59B |
| Bio-Thera Solutions | 7.08B |
| Shanghai OPM Biosciences | 6.88B |
| Zhejiang Ausun Pharmaceutical | 6.12B |
| Wuhan Keqian Biology Co.,Ltd | 6.04B |
| Jiangsu Aidea Pharmaceutical Group | 5.82B |
| Hangzhou Biotest Biotech | 5.59B |